1. Home
  2. ASMB vs KNDI Comparison

ASMB vs KNDI Comparison

Compare ASMB & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$30.71

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.89

Market Cap

67.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
KNDI
Founded
2005
2002
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
553.6M
67.8M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
KNDI
Price
$30.71
$0.89
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
154.5K
199.4K
Earning Date
11-10-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
$104,035,613.00
Revenue This Year
$33.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.30
N/A
52 Week Low
$7.75
$0.78
52 Week High
$39.71
$1.81

Technical Indicators

Market Signals
Indicator
ASMB
KNDI
Relative Strength Index (RSI) 40.46 48.72
Support Level $30.18 $0.80
Resistance Level $33.71 $0.93
Average True Range (ATR) 1.92 0.06
MACD -0.28 0.01
Stochastic Oscillator 19.43 55.59

Price Performance

Historical Comparison
ASMB
KNDI

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: